Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol. 2003;42:1161 70. 1219. Wijeysundera HC, Machado M, Farahati F, et al. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994 2005. JAMA. 2010;303:1841 7. 1220. Gimelli A, Rossi G, Landi P, et al. Stress/Rest Myocardial Perfusion Abnormalities by Gated SPECT: Still the Best Predictor of Cardiac Events in Stable Ischemic Heart Disease. J Nucl Med. 2009;50: 546 53. 1221. Hashimoto A, Nakata T, Wakabayashi T, et al. Incremental prognostic value of stress/rest gated perfusion SPECT in patients with coronary artery disease subanalysis of the J-ACCESS study. Circ J. 2009;73: 2288 93. 1222. Nakata T, Hashimoto A, Wakabayashi T, et al. Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the J-ACCESS database. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:1393 400. 1223. Shaw LJ, Hendel RC, Heller GV, et al. Prognostic estimation of coronary artery disease risk with resting perfusion abnormalities and stress ischemia on myocardial perfusion SPECT. J Nucl Cardiol. 2008; 15:762 73. 1224. Kang X, Shaw LJ, Hayes SW, et al. Impact of body mass index on cardiac mortality in patients with known or suspected coronary artery disease undergoing myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol. 2006;47:1418 26. 1225. D Agostino RB Sr, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286:180 7. 1226. Spertus JA, Winder JA, Dewhurst TA, et al. Development and eval- uation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995;25: 333 41. 1227. 